Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Medtronic
McKinsey
Johnson and Johnson
Moodys

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MISOPROSTOL

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Misoprostol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Bill and Melinda Gates Foundation N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Global Network for Women's and Children's Health Research N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Jawaharlal Nehru Medical College N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed John E. Fogarty International Center (FIC) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Cancer Institute (NCI) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Center for Complementary and Integrative Health (NCCIH) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Institute of Dental and Craniofacial Research (NIDCR) N/A 2002-09-01 Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Misoprostol

Condition Name

Condition Name for Misoprostol
Intervention Trials
Postpartum Hemorrhage 34
Cervical Ripening 21
Pregnancy 17
Abortion, Induced 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Misoprostol
Intervention Trials
Hemorrhage 73
Postpartum Hemorrhage 59
Abortion, Spontaneous 14
Abortion, Missed 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Misoprostol

Trials by Country

Trials by Country for Misoprostol
Location Trials
United States 171
Egypt 70
France 14
Vietnam 12
Canada 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Misoprostol
Location Trials
California 20
Pennsylvania 13
New York 13
Illinois 12
Texas 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Misoprostol

Clinical Trial Phase

Clinical Trial Phase for Misoprostol
Clinical Trial Phase Trials
Phase 4 93
Phase 3 64
Phase 2/Phase 3 21
[disabled in preview] 55
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Misoprostol
Clinical Trial Phase Trials
Completed 170
Recruiting 73
Not yet recruiting 61
[disabled in preview] 46
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Misoprostol

Sponsor Name

Sponsor Name for Misoprostol
Sponsor Trials
Gynuity Health Projects 58
Cairo University 22
Ain Shams University 22
[disabled in preview] 42
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Misoprostol
Sponsor Trials
Other 501
Industry 17
NIH 10
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Baxter
Merck
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.